Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia.
作者信息
Langabeer S E, Haslam K, Crampe M, MacDonagh B, McHugh J
机构信息
Cancer Molecular Diagnostics, St. James's Hospital, Dublin D08 E9P6, Ireland.
Department of Haematology, Tallaght University Hospital, Dublin D24 NR0A, Ireland.
出版信息
Exp Oncol. 2019 Mar;41(1):82-83. doi: 10.32471/exp-oncology.2312-8852.vol-41-no-1.12685.
Abstract
摘要
Zotero 插件